Literature DB >> 11095783

Chronic Meningitis.

.   

Abstract

Chronic meningitis may be caused by a large number of infectious agents, including spirochetes (Treponema pallidum, Borrelia burgdorferi), Mycobacterium tuberculosis, and fungi (primarily Cryptococcus neoformans). The incidence of these specific causes of chronic meningitis has been impacted since the advent of HIV infection, and new information is also available on how this epidemic has affected populations in developing countries of the world. In the area of diagnostics, the development of polymerase chain reaction has been a major advance that has increased our capabilities for identifying etiologic agents (such as M. tuberculosis) that are difficult to culture. Finally, the management of patients with chronic meningitis has evolved, and the availability of new antifungal agents and adjunctive strategies has changed the approach to the patient with cryptococcal meningitis.

Entities:  

Year:  1999        PMID: 11095783     DOI: 10.1007/s11908-996-0024-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  27 in total

1.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

2.  Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

Authors:  A C Leenders; P Reiss; P Portegies; K Clezy; W C Hop; J Hoy; J C Borleffs; T Allworth; R H Kauffmann; P Jones; F P Kroon; H A Verbrugh; S de Marie
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

3.  Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.

Authors:  R A Larsen; M A Leal; L S Chan
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

4.  Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis.

Authors:  A Bonington; J I Strang; P E Klapper; S V Hood; W Rubombora; M Penny; R Willers; E G Wilkins
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe.

Authors:  R S Heyderman; I T Gangaidzo; J G Hakim; J Mielke; A Taziwa; P Musvaire; V J Robertson; P R Mason
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

6.  Fluconazole monotherapy for cryptococcosis in non-AIDS patients.

Authors:  H Yamaguchi; H Ikemoto; K Watanabe; A Ito; K Hara; S Kohno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

7.  Neurosyphilis in acquired immunodeficiency syndrome.

Authors:  D A Katz; J R Berger
Journal:  Arch Neurol       Date:  1989-08

8.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

9.  Tuberculous meningitis: a 30-year review.

Authors:  S J Kent; S M Crowe; A Yung; C R Lucas; A M Mijch
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

10.  Shunt surgery in poor grade patients with tuberculous meningitis and hydrocephalus: effects of response to external ventricular drainage and other variables on long term outcome.

Authors:  J M Mathew; V Rajshekhar; M J Chandy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.